DR. THOMAS LOUIS NICKOLAS, M.D.
Osteopathic Medicine at 168 St, New York, NY

License number
New York 220952
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
622 W 168Th St, New York, NY 10032
Phone
(212) 305-3273

Personal information

See more information about THOMAS LOUIS NICKOLAS at radaris.com
Name
Address
Phone
Thomas Nickolas, age 53
365 Bridge St APT 3L, Brooklyn, NY 11201
Thomas L Nickolas, age 54
621 171St St, New York, NY 10032

Professional information

Thomas Nickolas Photo 1

Assistant Professor Of Medicine At Columbia University

Position:
Assistant Professor of Medicine at Columbia University
Location:
Greater New York City Area
Industry:
Hospital & Health Care
Work:
Columbia University - Assistant Professor of Medicine
Education:
Columbia University College of Physicians and Surgeons 2001 - 2004
MS, Biostatistics/Epidemiology
University of Pittsburgh School of Medicine 1993 - 1998
MD, Medicine
Rutgers, The State University of New Jersey-New Brunswick 1989 - 1993
BA, Biochemistry


Thomas Louis Nickolas Photo 2

Thomas Louis Nickolas, New York NY

Specialties:
Nephrologist
Address:
622 W 168Th St, New York, NY 10032
Education:
Doctor of Medicine
Board certifications:
American Board of Internal Medicine Sub-certificate in Nephrology (Internal Medicine)


Thomas Nickolas Photo 3

Methods And Compositions For Diagnosis Of Urosepsis And Urinary Tract Infection

US Patent:
2012021, Aug 23, 2012
Filed:
Jun 17, 2010
Appl. No.:
13/378986
Inventors:
Jonathan Barasch - New York NY, US
Catherine Forster - Wayne PA, US
Thomas L. Nickolas - New York NY, US
Neal Paragas - New York NY, US
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
G01N 33/566
US Classification:
435 792, 436501
Abstract:
Methods for diagnosis of and distinguishing between, urosepsis, sepsis, and urinary tract infections (UTIs) are disclosed The diagnostic methods are based on determining the level of NGAL protein in a bodily fluid sample, such as urine sample.


Thomas Nickolas Photo 4

Methods And Compositions For Diagnosis Of Urosepsis And Urinary Tract Infection

US Patent:
2013014, Jun 13, 2013
Filed:
Feb 6, 2013
Appl. No.:
13/761112
Inventors:
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK - New York NY, US
Catherine FORSTER - Wayne PA, US
Thomas L. NICKOLAS - New York NY, US
Neal PARAGAS - New York NY, US
Assignee:
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK - New York NY
International Classification:
G01N 33/68
US Classification:
435 792, 436501
Abstract:
The present invention is directed to methods for diagnosis of urosepsis, sepsis, and urinary tract infections (UTIs), and to methods for distinguishing between urosepsis, sepsis of other origins, and localized UTIs. In some aspects, the diagnostic methods of the invention are based on determining whether a bodily fluid sample, such as urine sample, contains an amount of NGAL protein that exceeds or is less than a certain threshold level, or that falls within a certain range. The present invention also provides diagnostic kits.


Thomas L Nickolas Photo 5

Dr. Thomas L Nickolas - MD (Doctor of Medicine)

Hospitals:
Columbia University Medical Center NEP
622 W 168Th St, New York 10032
Columbia University Medical Center NEP
622 W 168Th St, New York 10032
Education:
Medical Schools
University Of Pittsburgh School Of Medicine
Graduated: 1998


Thomas Nickolas Photo 6

Thomas Nickolas

Location:
Greater New York City Area
Industry:
Medical Practice


Thomas Nickolas Photo 7

Use Of Urinary Ngal To Distinguish Kidney Disease And Predict Mortality In Subjects With Cirrhosis

US Patent:
2010023, Sep 16, 2010
Filed:
Feb 12, 2010
Appl. No.:
12/704887
Inventors:
Jonathan BARASCH - New York NY, US
Thomas L. NICKOLAS - New York NY, US
International Classification:
G01N 33/53, G01N 33/566
US Classification:
435 792, 436 86, 436501
Abstract:
In one embodiment, the present invention is directed to methods for diagnosis of acute kidney injury (AKI) and hepatorenal syndrome (HRS) in cirrhosis patients, and to methods for distinguishing between AKI and/or HRS and/or other kidney diseases in cirrhosis subjects. In another embodiment, the present invention is directed to prognostic methods for predicting disease-specific mortality in cirrhosis patients. In some aspects, the diagnostic and prognostic methods of the invention are based on determining whether a bodily fluid sample, such as a urine sample, contains an amount of NGAL protein that exceeds or is less than a certain threshold level, or that falls within a certain range.


Thomas Nickolas Photo 8

Use Of Urinary Ngal To Diagnose Unilateral And Bilateral Urinary Obstruction

US Patent:
2010023, Sep 16, 2010
Filed:
Feb 12, 2010
Appl. No.:
12/704875
Inventors:
Jonathan BARASCH - New York NY, US
Thomas L. NICKOLAS - New York NY, US
International Classification:
G01N 33/53, G01N 33/00
US Classification:
435 792, 436 86
Abstract:
In one embodiment, the present invention is directed to methods for diagnosis of urinary tract obstruction (UTO), and to methods for distinguishing between unilateral and bilateral UTO. In some aspects, the diagnostic methods of the invention are based on determining whether a bodily fluid sample, such as a urine sample, contains an amount of NGAL protein that exceeds or is less than a certain threshold level, or that falls within a certain range. The present invention also provides diagnostic kits for the diagnosis of UTO and for distinguishing between unilateral and bilateral UTO.


Thomas Nickolas Photo 9

Use Of Urinary Ngal To Diagnose Unilateral And Bilateral Urinary Obstruction

US Patent:
2013023, Sep 5, 2013
Filed:
Apr 3, 2013
Appl. No.:
13/856339
Inventors:
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK - , US
Thomas L. NICKOLAS - New York NY, US
Assignee:
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK - NEW YORK NY
International Classification:
G01N 33/68
US Classification:
435 792
Abstract:
In one embodiment, the present invention is directed to methods for diagnosis of urinary tract obstruction (UTO), and to methods for distinguishing between unilateral and bilateral UTO. In some aspects, the diagnostic methods of the invention are based on determining whether a bodily fluid sample, such as a urine sample, contains an amount of NGAL protein that exceeds or is less than a certain threshold level, or that falls within a certain range. The present invention also provides diagnostic kits for the diagnosis of UTO and for distinguishing between unilateral and bilateral UTO.